Korean J Psychopharmacol.  2001 Jun;12(2):115-123.

Newer Antipsychotics:Serotonin and Glutamate Receptor Related Drugs

Affiliations
  • 1Department of Psychiatry, Yonsei University College of Medicine, Seoul, Korea. pr88@chollian.net

Abstract

Several decades of research attempting to explain schizophrenia regarding dopamine hyperactivity hypothesis have produced disappointing results. New hypotheses focusing on serotonin-dopamine interactions and hypofunction of the NMDA glutamate transmitter system have been emerging as potentially more promising concepts. The next generation of treatments for schizophrenia, whether they are based on dopamine, serotonin, or glutamate etc., should be effective on negative symptoms and cognitive deficits as well as positive symptoms. In this article, I review the brief overview of these hypotheses and new drugs based on the hypotheses.

Keyword

Schizophrenia; Serotonin; Glutamate
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr